Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universidad San Jorge
This is a randomized controlled trial of the efficacy of an individualized, progressive, exercise program (strength, cardiovascular, and breathing exercises) in recovering people from the post-COVID-19 syndrome (i.e., patients who present symptoms \>12 weeks once the acute phase of the disease is over). The primary objective of the study is to evaluate the clinical efficacy and safety of a tailored exercise-based treatment relative to the control arm in improving the subject clinical status in both ambulatory and hospitalized post-COVID-19 syndrome patients. The main novelty of this trial compared to other exercise-based interventions is the development and proof of concept of a progressively, levelled exercise regime for people with physical activity intolerance and fatigue symptoms.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
People over 18 years of age.
Persistent symptoms of COVID \>3 months of duration since infection.
Have no medical contraindications incompatible with the practice of exercise.
Do not meet the general 2020 recommendations for physical activity established by the World Health Organization2 (i.e., at least 150-300 minutes of moderate-intensity aerobic physical activity; or at least 75-150 minutes of vigorous-intensity aerobic physical activity; or an equivalent combination of moderate- and vigorous-intensity activity throughout the week).
Provide signed informed consent.
You may not be if
Presence of uncontrolled serious medical illness.
Presence of any medical, psychological or social problem that could seriously interfere with the patient's participation in the study.